Methods of treating migraine
AssigneeAllergan Pharmaceuticals International Limited
InventorsRamesh Boinpally, Joel Trugman
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods for the treatment of migraine by the administration of atogepant or a pharmaceutically acceptable salt thereof.
Claims16
1-21. (canceled)
A method for the preventive treatment of migraine in a patient having mild or moderate hepatic impairment, the method comprising orally administering a dose of 10 mg atogepant once daily to the patient, wherein the preventive treatment is safe and effective.
A method for the preventive treatment of migraine in a patient having mild or moderate hepatic impairment, the method comprising orally administering a dose of 30 mg atogepant once daily to the patient, wherein the preventive treatment is safe and effective.
A method for the preventive treatment of migraine in a patient having mild or moderate hepatic impairment, the method comprising orally administering a dose of 60 mg atogepant once daily to the patient, wherein the preventive treatment is safe and effective.
Dependencies are inferred from the claim text.